E E Vokes Selected Research

Alkaline Phosphatase

2/2016

Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E E Vokes Research Topics

Disease

27	Neoplasms (Cancer) 01/2023 - 01/2000
12	Head and Neck Neoplasms (Head and Neck Cancer) 03/2013 - 02/2000
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 04/2000
9	Squamous Cell Carcinoma of Head and Neck 01/2019 - 05/2001
5	Neutropenia 02/2016 - 11/2000
4	Esophageal Neoplasms (Esophageal Cancer) 08/2005 - 01/2001
3	Laryngeal Neoplasms (Laryngeal Cancer) 09/2008 - 03/2001
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2004 - 02/2001
3	Leukemia 02/2001 - 04/2000
2	Nasopharyngeal Carcinoma 01/2023 - 03/2013
2	Disease Progression 01/2023 - 06/2004
2	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2004
2	Diarrhea 02/2016 - 09/2000
2	Dyspnea (Shortness of Breath) 02/2016 - 01/2001
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016 - 10/2011
2	Carcinoma (Carcinomatosis) 09/2008 - 08/2005
2	Colorectal Neoplasms (Colorectal Cancer) 06/2004 - 08/2003
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2002 - 02/2000
2	Kidney Neoplasms (Kidney Cancer) 09/2000 - 01/2000
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Fatigue 02/2016
1	Headache (Headaches) 02/2016
1	Anorexia 02/2016
1	Nausea 02/2016
1	Vomiting 02/2016
1	Adenoid Cystic Carcinoma (Cylindroma) 02/2016
1	Chest Pain (Chest Pains) 02/2016
1	Lymphopenia (Lymphocytopenia) 02/2016
1	Febrile Neutropenia 08/2005
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2004
1	Pleural Effusion (Pleural Effusions) 06/2004
1	Colonic Neoplasms (Colon Cancer) 08/2003
1	Tics (Tic) 05/2003
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 04/2003
1	Adenocarcinoma 10/2001
1	Oropharyngeal Neoplasms 03/2001
1	Esophagitis 01/2001

Drug/Important Bio-Agent (IBA)

11	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 04/2000
7	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 06/2000
6	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2016 - 06/2000
5	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 04/2000
4	Vinorelbine (Navelbine)FDA LinkGeneric 02/2001 - 04/2000
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2005 - 06/2000
3	alvocidib (flavopiridol)IBA 08/2003 - 01/2000
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2018
2	Docetaxel (Taxotere)FDA Link 01/2018 - 02/2001
2	Bevacizumab (Avastin)FDA Link 01/2013 - 10/2011
2	Pemetrexed (MTA)FDA Link 11/2011 - 10/2001
2	Carboplatin (JM8)FDA LinkGeneric 10/2008 - 05/2003
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2005 - 06/2004
2	Ifosfamide FDA LinkGeneric 05/2003 - 04/2000
2	losoxantroneIBA 02/2002 - 02/2001
2	Isotretinoin (Accutane)FDA LinkGeneric 08/2001 - 04/2001
2	RetinoidsIBA 08/2001 - 04/2001
2	Gemcitabine FDA Link 02/2001 - 01/2001
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2000 - 01/2000
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023
1	cediranib (AZD2171)IBA 01/2023
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	IodineIBA 01/2023
1	NivolumabIBA 01/2018
1	EnzymesIBA 01/2018
1	Alanine Transaminase (SGPT)IBA 02/2016
1	Alkaline PhosphataseIBA 02/2016
1	Dasatinib (BMS 354825)FDA Link 02/2016
1	Cetuximab (Erbitux)FDA Link 01/2016
1	Everolimus FDA Link 01/2016
1	CarcinogensIBA 01/2015
1	RNA (Ribonucleic Acid)IBA 06/2013
1	Messenger RNA (mRNA)IBA 06/2013
1	Viral RNAIBA 06/2013
1	adenovirus receptorIBA 03/2013
1	Leucovorin (Folinic Acid)FDA Link 08/2005
1	ixabepilone (BMS 247550)FDA Link 06/2004
1	epothilone B (EPO906)IBA 06/2004
1	Excipients (Suspending Agents)IBA 06/2004
1	taxaneIBA 06/2004
1	flavoneIBA 08/2003
1	Drug CombinationsIBA 05/2003
1	Antisense OligonucleotidesIBA 04/2002
1	oblimersen (G3139)IBA 04/2002
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2002
1	SeleniumIBA 03/2001
1	9-aminocamptothecinIBA 01/2001
1	PlatinumIBA 01/2001

Therapy/Procedure

17	Chemoradiotherapy 01/2019 - 04/2000
16	Radiotherapy 01/2019 - 02/2000
13	Therapeutics 01/2023 - 02/2000
12	Drug Therapy (Chemotherapy) 01/2015 - 02/2000
11	Induction Chemotherapy 01/2019 - 08/2000
2	Combined Modality Therapy 04/2016 - 01/2001
2	Combination Drug Therapy (Combination Chemotherapy) 05/2003 - 06/2000
2	Chemoprevention 08/2001 - 04/2001
2	Adjuvant Radiotherapy 03/2001 - 03/2001
2	Tracheotomy 08/2000 - 03/2000
1	Aftercare (After-Treatment) 03/2013
1	Re-Irradiation 03/2013
1	Bufei Huoxue 10/2011
1	Intravenous Administration 02/2001